GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Viveve Medical Inc (OTCPK:VIVE) » Definitions » Shiller PE Ratio

Viveve Medical (Viveve Medical) Shiller PE Ratio : 0.00 (As of May. 26, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Viveve Medical Shiller PE Ratio?

As of today (2024-05-26), Viveve Medical's current share price is $0.0003. Viveve Medical's E10 for the quarter that ended in Sep. 2022 was $8,176.39. Viveve Medical's Shiller PE Ratio for today is 0.00.

The historical rank and industry rank for Viveve Medical's Shiller PE Ratio or its related term are showing as below:

VIVE's Shiller PE Ratio is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 26.19
* Ranked among companies with meaningful Shiller PE Ratio only.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Viveve Medical's adjusted earnings per share data for the three months ended in Sep. 2022 was $-0.590. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $8,176.39 for the trailing ten years ended in Sep. 2022.

Shiller PE for Stocks: The True Measure of Stock Valuation


Viveve Medical Shiller PE Ratio Historical Data

The historical data trend for Viveve Medical's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Viveve Medical Shiller PE Ratio Chart

Viveve Medical Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Viveve Medical Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Viveve Medical's Shiller PE Ratio

For the Medical Devices subindustry, Viveve Medical's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Viveve Medical's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Viveve Medical's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Viveve Medical's Shiller PE Ratio falls into.



Viveve Medical Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Viveve Medical's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=0.0003/8176.39
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Viveve Medical's E10 for the quarter that ended in Sep. 2022 is calculated as:

For example, Viveve Medical's adjusted earnings per share data for the three months ended in Sep. 2022 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Sep. 2022 (Change)*Current CPI (Sep. 2022)
=-0.59/125.2265*125.2265
=-0.590

Current CPI (Sep. 2022) = 125.2265.

Viveve Medical Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201212 75,025.000 96.871 96,985.769
201303 -113,159.000 98.209 -144,288.688
201306 95,734.900 98.518 121,689.141
201309 -3,903.850 98.790 -4,948.532
201312 25,461.500 98.326 32,427.413
201403 -15,461.500 99.695 -19,421.227
201406 10,586.400 100.560 13,183.218
201409 -1,111.900 100.428 -1,386.462
201412 -773.535 99.070 -977.767
201503 -1,100.000 99.621 -1,382.731
201506 -670.000 100.684 -833.318
201509 -500.000 100.392 -623.691
201512 -560.000 99.792 -702.727
201603 -550.000 100.470 -685.521
201606 -660.000 101.688 -812.774
201609 -460.000 101.861 -565.518
201612 -550.000 101.863 -676.151
201703 -570.000 102.862 -693.929
201706 -540.000 103.349 -654.310
201709 -500.000 104.136 -601.267
201712 -530.000 104.011 -638.105
201803 -490.000 105.290 -582.784
201806 -370.000 106.317 -435.809
201809 -390.700 106.507 -459.370
201812 -380.000 105.998 -448.934
201903 -216.300 107.251 -252.554
201906 -209.300 108.070 -242.528
201909 -135.100 108.329 -156.173
201912 -21.478 108.420 -24.807
202003 -8.170 108.902 -9.395
202006 -5.740 108.767 -6.609
202009 -2.650 109.815 -3.022
202012 -1.850 109.897 -2.108
202103 -0.800 111.754 -0.896
202106 -0.490 114.631 -0.535
202109 -0.670 115.734 -0.725
202112 -0.720 117.630 -0.767
202203 -0.670 121.301 -0.692
202206 -0.670 125.017 -0.671
202209 -0.590 125.227 -0.590

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Viveve Medical  (OTCPK:VIVE) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Viveve Medical Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Viveve Medical's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Viveve Medical (Viveve Medical) Business Description

Traded in Other Exchanges
N/A
Address
345 Inverness Drive South, Building B, Suite 250, Englewood, CO, USA, 80112
Viveve Medical Inc designs, develops, manufactures and markets a platform medical technology. Its Cryogen-cooled Monopolar Radiofrequency technology is delivered through a radiofrequency generator, handpiece and treatment tip, called the Viveve System. The Viveve System is for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The Viveve System is indicated for use and being marketed for use in general surgical procedures for electrocoagulation and hemostasis in the United States. It has a business presence in the US, Asia Pacific, Canada, Europe and Middle East and Latin America.
Executives
Presnell Sharon Collins director 6275 NANCY RIDGE DRIVE, SUITE 110, SAN DIEGO CA 92121
Goldman Sachs Group Inc 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Goldman Sachs & Co. Llc 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Wilmot B. Harkey 10 percent owner C/O NANTAHALA CAPITAL MANAGEMENT, LLC, 130 MAIN ST. 2ND FLOOR, NEW CANAAN CT 06840
Daniel Mack 10 percent owner C/O NANTAHALA CAPITAL MANAGEMENT, LLC, 130 MAIN ST. 2ND FLOOR, NEW CANAAN CT 06840
Nantahala Capital Management, Llc 10 percent owner 130 MAIN ST., 2ND FLOOR, NEW CANAAN CT 06840
Karen L. Zaderej director AXOGEN INC., 13859 PROGRESS BLVD, SUITE 100, ALACHUA FL 32615
Steven L Basta director 1875 S GRANT STREET SUITE 110, SAN MATEO CA 94402
Scott Durbin officer: Chief Financial Officer PO BOX 376, ANN ARBOR MI 48106
James G. Atkinson officer: CBO & President 150 COMMERCIAL STREET, SUNNYVALE CA 94086
Patricia Scheller director, officer: CEO and Director 150 COMMERCIAL STREET, SUNNYVALE CA 94086
Jon M Plexico director, 10 percent owner 16430 N SCOTTSDALE RD 450, SCOTTSDALE AZ 85254
Stonepine Capital Management, Llc director, 10 percent owner 919 NW BOND STREET, SUITE 204, BEND OR 97703
Timothy P Lynch director, 10 percent owner 919 NW BOND STREET, SUITE 204, BEND OR 97703
Daniel Janney director, 10 percent owner PO BOX 7414, JACKSON WY 83002